Biopartitioning micellar chromatography to predict skin permeability

Biomedical Chromatography

Volumn 17, Issue 8, 2003, Pages 530-537

  Martinez Pla J J ^a   Martin Biosca Y ^a   Sagrado, S ^a   Villanueva Camanas R M ^a   Medina Hernández, Maria J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Biopartitioning micellar chromatography; Quantitative retention activity relationships; Skin permeability constant

Indexed keywords

BIOCHEMISTRY; CHROMATOGRAPHY; FORECASTING; LEAST SQUARES APPROXIMATIONS; MECHANICAL PERMEABILITY; RISK ASSESSMENT;

ASSESSMENT PROCESS; BIOPARTITIONING MICELLAR CHROMATOGRAPHIES; COSMETIC INDUSTRY; DERMAL ABSORPTION; DERMAL EXPOSURE; EXPOSURE AND RISK ASSESSMENTS; PHARMACEUTICAL INDUSTRY; QUANTITATIVE RETENTION-ACTIVITY RELATIONSHIP; SKIN PERMEABILITY; SKIN PERMEABILITY CONSTANT;

PRINCIPAL COMPONENT ANALYSIS;

ALCOHOL; AMOBARBITAL; BUTANOL; CHLORPHENIRAMINE; CORTICOSTERONE; CORTISONE; CRESOL; EPHEDRINE; ESTRADIOL; ESTRIOL; ESTRONE; ETHYLBENZENE; FENTANYL; GLYCEROL; HYDROCORTISONE; HYDROXYPROGESTERONE; METHANOL; NAPROXEN; PHENOBARBITAL; PHENOL; PROGESTERONE; PROPANOL; RESORCINOL; SALICYLATE SODIUM; STYRENE; TESTOSTERONE; THIOUREA; UNINDEXED DRUG; UREA; XENOBIOTIC AGENT;

ARTICLE; CONTROLLED STUDY; DRUG RETENTION; IN VITRO STUDY; IONIC STRENGTH; MELTING POINT; MICELLE; MULTIVARIATE ANALYSIS; PH; PHYSICAL CHEMISTRY; QUANTITATIVE ANALYSIS; SKIN ABSORPTION; SKIN PERMEABILITY;

EID: 0347519168     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.281     Document Type: Article

References (40)

1. Abraham MH. Chem. Soc. Rev. 1993; 23: 660.
2. Abraham MH, Martins F and Mitchell RC. Journal of Pharmacy and Pharmacology 1997; 49: 858.
3. Al-Haj MA, Kaliszan R and Nasal A. Analytical Chemistry 1999; 71: 2976.
4. De Vito SC. Absorption through cellular membranes. In Handbook of Property Estimation Methods for Chemicals, Boethling RS and Mackay D (eds). CRC Press: Boca Raton, FL, 2000.
5. Dorsey JG and Khaledi MG. Journal of Chromatography A 1993; 656: 485.
6. Escuder-Gilabert L, Sagrado S, Villanueva-Camañas RM and Medina-Hernández MJ. Analytical Chemistry 1998a; 70: 28.
7. Escuder-Gilabert L, Sanchis-Mallols JM, Sagrado S, Medina-Hernández MJ and Villanueva-Camañas RM. Journal of Chromatography A 1998b; 823: 549.
8. Escuder-Gilabert L, Sagrado S, Villanueva Camañas RM and Medina-Hernández MJ. Journal of Chromatography B 2000; 740: 59.
9. Escuder-Gilabert L, Martín-Biosca Y, Sagrado S, Villanueva-Camañas RM and Medina Hernández MJ. Analytica Chimica Acta 2001; 448: 173.
10. Exposure Assessment Group. Dermal Exposure Assessment: Principles and Applications, EPA/600/8-91/011B. Environmental Protection Agency: Washington, DC, 1992.
11. Guyton AC. Tratado de Fisiología Médica, 8th edn. Interameriacana McGraw-Hill: Madrid, 1994.
12. Hansch C and Leo A. Substituent Constant for Correlation Analysis in Chemistry and Biology. Wiley Interscience: New York, 1987.
13. Ishihama Y and Asakawa N. Journal of Pharmaceutical Science 1999; 88: 1305.
14. Jezierska M, Cendrowska I, Markuszewski M, Kaliszan R and Buszewski B. Chromatographia 2000; 51(1-2): 111.
15. Kaliszan R. TRAC 1999; 18: 400.
16. Kamlet MJ, Abraham MH, Carr PW, Doherty RM and Taft RW. Journal of the Chemical Society, Perkin Transactions 1988; 2: 2087.
17. Lambert WJ. Journal of Chromatography A 1993; 656: 469.
18. Lieb WR and Stein WD. Transport and Diffusion across Cell Membranes, Stein WD (ed.). Academic Press: New York, 1986.
19. Lien EJ and Gao H. Pharmaceutical Research 1995; 12: 583.
20. Lundqvist A and Lundahl P. Journal of Chromatography B 1997; 699: 209.
21. Martens H and Naes T. Multivariate Calibration. Wiley: Chichester, 1989.
22. Martín-Biosca Y, Escuder-Gilabert L, Marina ML, Sagrado S, Villanueva-Camañas RM and Medina-Hernández MJ. Analytica Chimica Acta, 2001; 443: 191.
23. Martínez-Pla JJ, Sagrado S., Villanueva-Camañas RM and Medina-Hernández MJ. Journal Chromatography B 2001; 757: 89.
24. Molero-Monfort M, Martín-Biosca Y, Sagrado S, Villanueva-Camañas RM and Medina-Hernández MJ. Biomedical Chromatography 1999; 13: 394.
25. Molero-Monfort M, Martín-Biosca Y, Sagrado S, Villanueva-Camañas RM and Medina-Hernández MJ. Journal of Chromatography A 2000; 870: 1.
26. Molero-Monfort M, Escuder-Gilabert L, Villanueva Camañas RM, Sagrado S and Medina-Hernández MJ. Journal of Chromatography B 2001; 753(2): 225.
27. Morimoto Y, Hatanaka T, Sugibayashi K, Omiya H. Journal of Pharmacy and Pharmacology 1992; 44: 634.
28. Moss GP, Dearden JC, Patel H and Cronin MTD. Toxicology in vitro 2002; 16: 299.
29. Nasal A, Sznitowska M, Bucinski A and Kaliszan R. Journal of Chromatography A 1995; 692: 83.
30. Ong S, Liu H and Pidgeon C. Journal of Chromatography A 1996; 728: 113.
31. Patel H, Berge W and Cronin MTD. Chemosphere 2002; 48: 603.
32. Potts RO and Guy RH. Pharmaceutical Research 1992; 9: 663.
33. Potts RO and Guy RH. Pharmaceutical Research 1995; 12: 1628.
34. Pugh WJ, Degim IT and Hadgraft J. International Journal of Pharmacy 2000; 197: 203.
35. Quiñones-Torrelo C, Martín-Biosca Y, Martínez-Pla JJ, Sagrado, S, Villanueva-Camañas RM and Medina-Hernández MJ. Mini-Reviews in Medicinal Chemistry 2002; 2: 145.
36. Sanchis-Mallols JM, Villanueva-Camañas RM, Sagrado S and Medina-Hernández MJ. Chromatographia 1997; 46: 605.
37. Tsantili-Kakoulidou A, Varvaresou A, Siatra-Papastaikoudi T and Raevsky OA. Quantitative Structure-Activity Relationships 1999; 18(5): 482.
38. Turowski M and Kaliszan R. Journal of Pharmaceutical Biomedicine 1997; 15: 1325.
39. Voet D and Voet J. Bioquímica. Omega: Barcelona, 1992.
40. Wenkers BP and Lippold BC. Journal of Pharmaceutical Sciences 1999; 88: 1326.